Singapore's Temasek invests in Sun Pharmaceutical

Singapore government-controlled investment group Temasek is not deterred by the experience of Daiichi Sankyo and Ranbaxy Laboratories. It has invested more than half a million dollars in Ranbaxy buyer Sun Pharmaceutical as well as other Indian drugmakers. More from FiercePharmaAsia